Renibus Therapeutics

Provider of therapeutics to treat kidney diseases

placeSouthlake, Texas, United States calendar_todayFounded 2013 groups19 employees language renibus.com

Innovation

14 patent families (5 granted) — focus: Human necessities, Physics & computing, Chemistry & metallurgy; filing pace steady. Cited 457 times.

YearFilings
20191
20204
20216
20223
20236
20248
20258

Social engagement

Social engagement: 3.3K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Private equity133%
Bank & private debt133%

Recent activity

22 Jun 2026
Event
BIO International Convention
6 May 2026
Event
National Kidney Foundation 2026 Spring Clinical Meetings (#SCM26)
30 Apr 2026
Event
American Association for Thoracic Surgery (AATS) Annual Meeting oral presentation on Phase 3 PROTECT study of RBT-1
Coming soon